Literature DB >> 8267182

Effect of mannitol on cerebrospinal fluid dynamics and brain tissue edema.

T Donato1, Y Shapira, A Artru, K Powers.   

Abstract

Mannitol is used widely to decrease intracranial pressure (ICP); however, the mechanism by which this effect occurs is unclear. This study was designed to examine the effects of mannitol on cerebrospinal fluid (CSF) formation rate (Vf), resistance to reabsorption of CSF (Ra), and brain tissue water content (BTWC). Eighteen New Zealand White rabbits were allocated into one of three groups and studied at baseline and at two sequential doses of 20% mannitol: 0.75 g/kg followed by 4.4 mg.kg-1.min-1, and 2.0 g/kg (1.25 g/kg added to the initial dose of 0.75 g/kg) followed by 8.6 mg.kg-1.min-1. In Group 1, closed ventriculocisternal perfusion (VCP) was performed to determine changes in ICP due to mannitol. In Group 2, the increase in CSF osmolality due to mannitol was determined. In Group 3, mock CSF was used for open VCP to determine Vf and Ra. At the conclusion of each study, brain tissue samples were taken for determination of BTWC. Mannitol increased CSF and plasma osmolality. Ra was increased by 104% with the low dose of mannitol and not significantly changed by the high dose. Mannitol decreased BTWC, Vf (by 49% with the high dose), ICP, and hematocrit. The authors conclude that two of the mechanisms contributing to decreased ICP with mannitol are: 1) decreased CSF volume as indicated by decreased Vf, and 2) decreased brain tissue volume as indicated by decreased BTWC.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8267182     DOI: 10.1213/00000539-199401000-00011

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  18 in total

Review 1.  Osmotic therapy: fact and fiction.

Authors:  Michael N Diringer; Allyson R Zazulia
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

2.  Variation in osmotic response to sustained mannitol administration.

Authors:  Salah G Keyrouz; Rajat Dhar; Michael N Diringer
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

3.  Treatment of traumatic brain injury in pediatrics.

Authors:  Andranik Madikians; Christopher C Giza
Journal:  Curr Treat Options Neurol       Date:  2009-11       Impact factor: 3.598

4.  Cerebral blood flow velocity after mannitol infusion in children.

Authors:  S G Soriano; M L McManus; L J Sullivan; M A Rockoff; P M Black; F A Burrows
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

5.  Malignant cerebral edema after large anterior circulation infarction: a review.

Authors:  Allison E Arch; Kevin N Sheth
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-01

6.  Intravenous mannitol in status migrainosus treatment: a clinical case series.

Authors:  Roberto De Simone; Angelo Ranieri; Guido Ferra; Federico Cautiero
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

7.  Effects of hypertonic saline - hydroxyethyl starch and mannitol on serum osmolality, dural tension and hemodynamics in patients undergoing elective neurosurgical procedures.

Authors:  Jiao Li; Baoguo Wang; Shuangyan Wang; Feng Mu
Journal:  Int J Clin Exp Med       Date:  2014-08-15

8.  Effect of mannitol on cerebral blood volume in patients with head injury.

Authors:  Michael N Diringer; Michael T Scalfani; Allyson R Zazulia; Tom O Videen; Rajat Dhar; William J Powers
Journal:  Neurosurgery       Date:  2012-05       Impact factor: 4.654

9.  Therapeutic targeting of astrocytes after traumatic brain injury.

Authors:  Jessica Shields; Donald E Kimbler; Walid Radwan; Nathan Yanasak; Sangeetha Sukumari-Ramesh; Krishnan M Dhandapani
Journal:  Transl Stroke Res       Date:  2011-11-09       Impact factor: 6.829

10.  Accumulated mannitol and aggravated cerebral edema in a rat model of middle cerebral artery infarction.

Authors:  Jaeman Cho; Yeon-Hee Kim; Hyung Soo Han; Jaechan Park
Journal:  J Korean Neurosurg Soc       Date:  2007-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.